WebMar 17, 2024 · The share price of Esperion Therapeutics (ESPR Quick Quote ESPR - Free Report) lost 54.3% on Mar 16 after management reported a disagreement with one of its partners over certain milestone payments. WebMar 16, 2024 · But Esperion was optimistic, saying a new label could more than double the pool of patients eligible to take the pill. According to the agreement with Daiichi, Esperion would qualify for the $300 million payment with a new EU label citing cardiovascular risk reduction of 20% or more. Risk reduction between 15% and 20% would qualify for a $200 ...
Guest column: What happened with Esperion - Endpoints News
WebApr 18, 2024 · Reach out to Amber Tong. On April 1, Endpoints News editor-in-chief and founder John Carroll issued an open offer to biotech startup execs/VCs of failed biotechs … WebMar 6, 2024 · Esperion’s U.S. product revenue for 2024 was $56 million. Nexletol’s biggest competitor is injectable PCSK9s. Amgen’s Repatha posted $1.296 B in 2024 sales. … divinity gareth
Esperion Therapeutics CEO steps down; COO promoted to top role
WebMar 17, 2024 · March 17, 2024, 12:57 PM · 5 min read. The share price of Esperion Therapeutics ESPR lost 54.3% on Mar 16 after management reported a disagreement with one of its partners over certain milestone ... WebApr 11, 2024 · In other news, CEO Sheldon L. Koenig sold 5,441 shares of Esperion Therapeutics stock in a transaction dated Tuesday, March 7th. The shares were sold at … WebMar 10, 2024 · In the past week, the share price of Esperion Therapeutics ESPR was down 24% compared with the industry ’s 2.3% fall. The primary reason behind the drastic fall in … divinity fort joy arena